AR and hepatocellular carcinoma: We confirmed the existence of AR-SVs within HCC and determined through analyses of TGCA data that 78% of HCC patients had intra-tumoral AR-SV expression and subsequently discovered that in the patients with the most abundant AR mRNA, AR-SVs accounted for roughly one quarter of expressed AR.